Stephanie Lovell, Director at Cyclerion Therapeutics, holds 2.87K shares in TransMedics Group (Ticker: TMDX), holds 2.42K shares in Cyclerion Therapeutics (Ticker: CYCN). Most recently, Stephanie Lovell Sold ― shares of TransMedics Group on Mar 06, 2026 for an estimated value of $178.50K.
What is the percentage of profitable transactions made by Stephanie Lovell?
The percentage of profitable transactions made by Stephanie Lovell is 50%.
What is the average return per transaction made by Stephanie Lovell?
The average return per transaction made by Stephanie Lovell is -5.20%.
What stocks does Stephanie Lovell hold?
Stephanie Lovell holds: CYCN, TMDX stocks.
What was Stephanie Lovell’s latest transaction?
Stephanie Lovell latest transaction was an Informative Sell of $178.50K.
What was Stephanie Lovell's most profitable transaction?
Stephanie Lovell’s most profitable transaction was an Informative Sell of TMDX stock on March 6, 2026. The return on the trade was 4.70%.
What is Stephanie Lovell's role in Cyclerion Therapeutics?
Stephanie Lovell's role in Cyclerion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.